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VirulenceCollectins in airway ﬂuids and membrane-associated lectins such as the macrophage mannose receptor
(MMR) recognize mannose-rich glycans on the envelope glycoproteins of inﬂuenza A viruses. In this study,
we used a reverse genetic approach to examine the role of particular N-linked glycosylation sites on the
hemagglutinin (HA) of A/Beijing/353/89 (Beij/89, H3N2) in determining sensitivity to lectin-mediated
immune defenses and virulence in mice. We generated 7:1 reassortant viruses on an A/PR/8/34 ‘backbone’
with Beij/89 HA or HA lacking one or more glycosylation sites. Asn165 was an important determinant of
sensitivity to mouse collectins and virulence but did not alter susceptibility of airway macrophages to
infection. Removal of both Asn165 and Asn246 led to a further increase in virulence, characterized by enhanced
virus replication, pulmonary inﬂammation and vascular leak. These studies deﬁne the importance of
particular glycans on H3 HA in determining sensitivity to airway collectins and virulence in mice.y and Immunology, University
1540.
ing).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Glycans on the inﬂuenza A virus hemagglutinin (HA) are attached
via N-glycosidic linkages to Asn residues of the conserved glycosyl-
ation site motif Asn-X-Ser/Thr, where Xmay represent any amino acid
except proline (Kornfeld and Kornfeld, 1985). Oligosaccharides
attached to the stalk region of the viral HA are generally well
conserved between virus strains and are thought to play a role in
appropriate folding and HA conformation (Daniels et al., 2003;
Nobusawa et al., 1991; Ohuchi et al., 1997b; Roberts et al., 1993). In
contrast, glycans present on the globular head of HA are variable in
both structure and number (Abe et al., 2004; Wagner et al., 2000).
Since the appearance of H3N2 subtype viruses in the human
population in 1968, additional glycosylation sites have been progres-
sively added to the globular head of HA (Abe et al., 2004; Cherry et al.,
2009; Seidel et al., 1991) and recent circulating H3N2 human strains
contain as many as 8–10 potential glycosylation sites on the head of
HA (Zhang et al., 2004). Although NA is also glycosylated, there is no
general trend for increasing glycosylation sites on the human N2
(Zhang et al., 2004).
The addition of carbohydrate moieties to the globular head may
shield or modify antigenic sites (Skehel and Wiley, 2000) to prevent
recognition by antibodies elicited to previously circulating virusstrains. The loss or gain of carbohydrate on HA can also affect
biological properties of the virus by altering afﬁnity of HA for host cell
receptors (Anders et al., 1990; Ohuchi et al., 1997a), modulating
proteolytic cleavage of the HA0 precursor (Kawaoka and Webster,
1989) or disrupting the balance between receptor binding activity and
efﬁcient particle release (Klenk et al., 2002).
Innate host defenses have evolved to detect N-linked glycans
present on the surface of microbial pathogens. Collectins in respira-
tory secretions, such as SP-D, play an important role during inﬂuenza
virus infections by binding to mannose-rich glycans on the viral HA/
NA glycoproteins (Hartshorn et al., 1997; Hartshorn et al., 2000;
Reading et al., 1997). In addition, the murine macrophage mannose
receptor (MMR) binds to mannose-rich glycans on HA/NA to facilitate
uptake and destruction of virus by macrophages (Mϕ) (Reading et al.,
2000; Upham et al., 2010). For H3 subtype viruses, resistance to β-
inhibitors, including SP-D, is associated with loss of N-glycosylation
site Asn165 from the tip of the HA glycoprotein (Anders et al., 1990;
Hartley et al., 1992). In the case of Phil/82 (H3N2), loss of Asn165 was
also associated with a marked increase in virulence in mice (Hartley
et al., 1997). Mutants of A/Beijing/353/89 (Beij/89; H3N2) lacking
glycosylation site Asn246 also showed reduced sensitivity to rat SP-D
and increased virulence in mice (Reading et al., 2009). Furthermore,
sequential addition of N-linked glycosylation to the HA of H3 subtype
virus A/HongKong/1/68 was associated with increased sensitivity to
SP-D and reduced virulence inmice (Vigerust et al., 2007), although in
this study loss of Asn165 was not associated with increased virulence.
Based on these ﬁndings, we hypothesized that the levels of mannose-
rich glycans expressed on the viral HA would determine sensitivity of
Fig. 1. The HA of Beij/89 is a target for recognition by innate immune defenses and
attenuates virulence in mice. (A) HA monomers of A/PR/8/34 (H1, PR8), which lacks
potential N-linked glycosylation sites on the globular head of the HA and A/Beijing/353/
89 (H3, Beij/89) which carries 4 potential glycosylation sites on the head of HA. Green
circles identify the location of the Asn-X-Ser/Thr motif, indicative of a potential
glycosylation site. Note that 5 potential N-linked glycosylation sites are present on HA
stalk of each virus. The amino acid numbering of speciﬁc N-glycosylation sites on the
head of Beij/89 HA is indicated (H3 numbering). Images are derived from the crystal
structure of the HA of A/Aichi/2/68 (H3) and were generated using the MacPyMol
software and the solved HA structure (ID 3EYM, NCBI database). (B) Dilutions of BAL in
TBS containing 10 mM CaCl2 were mixed with BJx109 or PR8, or with RG-PR8-Beij-HA
or RG-PR8-Beij-NA. After 30 min at 37 °C, the amount of infectious virus remaining was
determined by ﬂuorescent focus assay. (C) Monolayers of (i) mouse Mϕ or (ii) LA-4
epithelial cells were incubated with 106 PFU of BJx109, PR8, RG-PR8-Beij-HA or RG-
PR8-Beij-NA for 1 h, washed, incubated a further 7 h and ﬁxed and stained by
immunoﬂuorescence for expression of newly synthesized viral NP. Inhibition of
infection was examined by addition of mannan to cell monolayers 30 min prior to the
addition of virus, such that mannan was present at a ﬁnal concentration of 10 mg/ml
(gray bars). Data represent the mean percent infection (±1 SD) from a minimum of 4
independent ﬁelds per chamber. (D) Groups of 5 mice were infected with 105 PFU of
BJx109, PR8, RG-PR8-Beij-HA or RG-PR8-Beij-NA. Mice were observed daily for weight
loss and mice that had lost ≥25% of their original body weight or presented with
pneumonia were euthanized. Data represents the average % weight change±1 SEM.
The p values for survival proportions were obtained using the Mantel Cox log rank test.
105 PFU: BJx109 or RG-Beij-HA vs. PR8 or RG-PR8-Beij-NA, pb0.01.
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will affect virulence.
In this study, we used a reverse genetic approach to examine the
role of particular N-linked glycosylation sites on the HA of Beij/89
(H3N2) in determining sensitivity to lectin-mediated immune
defenses and virulence in mice. We have used reverse genetics (RG)
to generate 7:1 reassortant viruses on a A/PR/8/34 (PR8, H1N1)
‘backbone’ which express either wild-type Beij/89 HA or HA lacking
one or more sites of N-linked glycosylation. Results presented herein
demonstrate that glycosylation sites Asn165 and Asn246 are particu-
larly important in determining sensitivity to collectins present in
mouse airway ﬂuids and virulence in mice. Surprisingly, loss of
glycosylation from HA did not alter the ability of viruses to infect Mϕ.
The severe disease induced by glycosylation mutant viruses was
characterized by increased virus replication, pulmonary inﬂammation
and vascular leak in the airways. Together, studies demonstrate the
importance of particular glycans on Beij/89 HA in determining
sensitivity to airway collectins and virulence in mice.
Results
The HA of inﬂuenza viruses plays a critical role in determining sensitivity
to innate host defenses and virulence in mice
The HA of Beij/89 (H3N2) contains 4 potential sites of N-linked
glycosylation on the globular head of HA, as shown in Fig. 1A. In
contrast, PR8 (H1N1) lacks N-glycosylation on the head of its HA
molecule. The HA stalk of Beij/89 and PR8 express similar numbers
(i.e. 5) of potential N-glycosylation sites. To determine the relative
contribution of HA and NA to (i) innate immune defenses, including
neutralization by mouse lung ﬂuids and uptake by Mϕ, and (ii)
virulence in mice, RG was used to insert either HA or NA from Beij/89
into the 7-gene backbone of PR8 to generate the 7:1 viruses RG-PR8-
Beij-HA and RG-PR8-Beij-NA.
We compared the sensitivity of BJx109 and PR8 viruses, and RG-
PR8-Beij-HA and RG-PR8-Beij-NA, to neutralization by mouse BAL
ﬂuid (Fig. 1B). Dilutions of mouse BAL were prepared in TBS-Ca, prior
to the addition of each virus. BJx109 was sensitive to neutralization by
mouse BAL (Fig. 1B) and neutralization was reversed in the presence
of mannan (data not shown), consistent with SP-D acting as themajor
neutralizing activity in BAL (Tate et al., 2010a). Moreover, PR8 was
largely resistant to mouse BAL (Fig. 1B) and neutralization was
unaffected in the presence of mannan (data not shown). Like BJx109,
RG virus expressing the HA of Beij/89 (RG-PR8-Beij-HA) was
neutralized by mouse BAL whereas RG-PR8-Beij-NA, like PR8, was
resistant. These results demonstrate that the viral HA is critical in
determining sensitivity to neutralization by mannose-speciﬁc lectins
present in mouse airways ﬂuids.
We next determined the contribution of HA and NA to the
susceptibility of murine Mϕ to infection by inﬂuenza viruses.
Consistent with previous studies (Reading et al., 2000; Reading
et al., 2010; Tate et al., 2010b), BJx109 infected ~90% of Mϕ (Fig. 1Ci)
and this was inhibited by the addition of mannan (data not shown),
whereas an equivalent inoculum dose of PR8 infected Mϕ poorly.
Expression of the HA of Beij/89 was important in determining the
susceptibility of Mϕ to infection as RG-PR8-Beij-HA infected Mϕ
efﬁciently compared to RG-PR8-Beij-NAwhich did not. No differences
were noted in the ability of BJx109, PR8 or RG viruses to infect a
murine lung epithelial cell line (Fig. 1Cii). Thus, the HA of Beij/89
promotes efﬁcient infection of Mϕ and epithelial cells whereas
expression of PR8 HA facilitates efﬁcient infection of epithelial cells
only.
Next, mice were infected with 105 PFU of BJx09 or PR8, or with an
equivalent dose of RG-PR8-Beij-HA or RG-PR8-Beij-NA. Mice infected
with BJx109 or RG-PR8-Beij-HA did not lose weight over the 10-day
monitoring period (Fig. 1D). In contrast, mice infectedwith PR8 or RG-
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post-infection. PR8 is a mouse-adapted virus (Taylor, 1941), however
expression of the Beij/89 HA on a ‘PR8 backbone’ enhanced sensitivity
to neutralizing inhibitors in mouse airway ﬂuids and efﬁcient
infection of murine Mϕ, and this was associated with attenuated
virulence in mice.
Generation of RG inﬂuenza viruses with differing numbers of
N-glycosylation sites on the head of HA
We hypothesized that the degree of glycosylation on the head of
the Beij/89 HA is likely to be a major factor determining sensitivity to
lectin-mediated defenses and therefore virulence in vivo. Therefore,
we aimed to individually or sequentially remove N-glycosylation sites
from head of the Beij/89 HA and use RG to generate viruses bearing
wild type (WT) Beij/89 HA or Beij/89 HA with altered glycosylation.
Viruses expressing WT or glycosylation mutant Beij/89 HA and the
remaining7 genes fromPR8were rescuedusing the 8-plasmidRG system
(Neumann et al., 1999). We rescued a series of single-step (–63, –126, –
165 and –246) and double-step (–63/126 and –165/246) glycosylation
mutants. A mutant lacking 3 glycosylation sites (−63/126/165) was
recovered but titers were very low and this virus was not used in
subsequent experiments. Despitemultiple attempts, we could not rescue
a HA glycosylation mutant with all 4 sites removed from the head of HA,
suggesting that the constellation of glycosylation sites on Beij/89 HA are
critical for its function and/or stability.
Glycosylation on the head of HA is a critical factor modulating the
virulence of inﬂuenza viruses for mice
To examine the effect of removal of N-glycosylation sites on
virulence, mice were infected with 105 PFU (Fig. 2A) of RG viruses
expressing WT HA or HA with altered glycosylation. Mice infected
with 105 PFU of RG virus expressing WT Beij/89 HA (WT) did not
show signiﬁcant weight loss over the 10-day monitoring period
(Fig. 2A). Single-step glycosylation mutants lacking site 63 (−63) or
126 (−126) did not show signiﬁcant weight loss, however simulta-
neous removal of both sites (−63/126) resulted in mild, but
signiﬁcant, weight loss. Consistent with previous reports (Hartley
et al., 1997; Reading et al., 2009), single-step glycosylation mutants
lacking site 165 (−165) or 246 (−246) lost weight and all animalsFig. 2. The inﬂuence of HA glycosylation on virulence in mice. Groups of 5 mice were infecte
Beij/89 HA or with Beij/89 HA lacking particular glycosylation sites. Mice were monitored da
with pneumonia were euthanized. Data represents the mean % weight change±1 SEM. Th
105 PFU: WT vs. −165, −246, −165/246, pb0.01. 103 PFU: WT vs. −165, pb0.01.succumbed to disease at day 5 or 8, respectively. Simultaneous
deletion of both sites (−165/246) was associated with accelerated
weight loss and death of all infected animals by day 4 post-infection.
To gain more insight into the role of glycosylation in attenuating
virulence, we inoculated mice with 103 PFU of RG viruses (Fig. 2B). RG
viruses lacking site 165 (−165) or 246 (−246) induced disease and
death inmice following inoculationwith 105 PFU (Fig. 2A), but did not
induce disease at the lower dose. The −165/246 mutant retained
virulence at the lower dose and all infected animals were euthanized
by day 6 post-infection.
Together these data demonstrate that deletion of particular sites of
N-glycosylation from the HA of Beij/89 was associated with enhanced
virulence in mice (Fig. 2). We next compared RG glycosylation
mutants in a number of in vitro assays to determine: (i) receptor
speciﬁcity of the HA for particular sialic acid (SA) linkages, (ii) ability
to infect murine epithelial cells and Mϕ, and (iii) sensitivity of to
innate immune proteins present in mouse BAL.
Receptor speciﬁcity of the HA of glycosylation mutant viruses
Glycans attached to the HA can inﬂuence preference for binding to
α(2,3)-Gal or α(2,6)-Gal-linked SA (Anders et al., 1990; Hartley et al.,
1997; van Eijk et al., 2004). RGviruseswere compared for their ability to
agglutinate erythrocytes from different species that are known to bear
differing patterns of sialylated receptors (Eylar et al., 1962; Ito et al.,
1997;Medeiros et al., 2001). Nomajor differences were observed in the
ability of RG viruses to agglutinate human (α(2,6)-Nα(2,3)-Gal-linked
Neu5Ac), chicken (α(2,3)-Nα(2,6)-Gal-linked Neu5Ac) or turkey
erythrocytes (α(2,6)-Nα(2,3)-Gal-linkedNeu5Ac) (Table 1A), whereas
viruses lacking Asn165 alone (−165) or in combination (−165/246)
acquired the ability to agglutinate horse erythrocytes, albeit weakly.
Horse erythrocytes express only α(2,3)-Gal-linked Neu5Gc (Ito et al.,
1997; Suzuki et al., 1985), indicating that mutants lacking Asn165 could
recognize this linkage. These ﬁndings are consistent with previous
reports that lossofAsn165 from theH3HAwasassociatedwith increased
binding toα(2,3)-Gal-linkedNeu5Gc (Anders et al., 1990; Hartley et al.,
1997; van Eijk et al., 2004). When human erythrocytes were
desialylated and enzymatically resialylated to express either α(2,3)-
Gal or α(2,6)-Gal-linked Neu5Ac (Table 1B), no differences were
observedbetweenRGvirus bearingWTBeij/89HAand the−165,−246
or−165/246 mutant viruses.d via the intranasal route with (A) 105 PFU or (B) 103 PFU of RG viruses bearing the WT
ily over a 10-day period. Mice that lost ≥25% of their original body weight or presented
e p values for survival proportions were obtained using the Mantel Cox log rank test.
Table 1
Receptor speciﬁcity of RG inﬂuenza A viruses.
A. Hemagglutination titera
HA glycosylation mutant Chicken Horse Human Turkey
WT 16 b1 16 16
−165 16 4b 8 16
−246 16 b1 8 8
−165/246 16 4b 8 16
B. Hemagglutination titerc
HA glycosylation mutant Native Asialo α(2,3)-SA α(2,6)-SA
WT 64 b1 b1 16
−165 64 b1 b1 16
−246 64 b1 b1 32
−165/246 64 b1 b1 16
a Viruses bearing WT HA or mutant HA were standardized to 16 HAU using chicken
erythrocytes and then tested for their ability to agglutinate horse, human and turkey
erythrocytes. Results are expressed as HAU.
b A ≥4-fold difference in HAU titer compared to virus expressing WT HA.
c Viruses bearing WT or mutant HA were compared for their ability to agglutinate
desialylated (Asialo) and enzymatically resialylated erythrocytes. Human erythrocytes
were desialylated with bacterial sialidase from C. perfringens and enzymatically
resialylated with Neu5Ac in the presence of either α(2,3)-ST or α(2,6)-ST. Native
human erythrocytes were included for comparison. HA assays were performed using
standard procedures and data are expressed as HAU.
Fig. 3. Inﬂuence of HA glycosylation on ability of RG inﬂuenza viruses to infect murine
cells and on sensitivity to neutralization by mouse BAL. Monolayers of (A) LA-4
epithelial cells (epithelial cells) or (B) mouse Mϕ (Mϕ) were incubated with increasing
concentrations of RG viruses bearing the WT Beij/89 HA or with Beij/89 HA
glycosylation mutants. After 1 h, monolayers were washed, incubated a further 7 h
and then ﬁxed and stained by immunoﬂuorescence for expression of newly synthesized
viral NP. Data represent the mean percent infection (±1 SD) from a minimum of 4
independent ﬁelds per chamber. *Infection is signiﬁcantly increased compared to virus
expressing WT HA (pb0.05, one-way ANOVA). (C) Dilutions of clariﬁed BAL in TBS
supplemented with 10 mM CaCl2 were mixed with RG viruses, incubated for 30 min at
37 °C and added to MDCK cell monolayers. The amount of infectious virus remaining
was determined by ﬂuorescent focus assay at 8 h post-infection.
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epithelial cells
Inﬂuenza virus infection of airway epithelial cells leads to
productive replication and virus ampliﬁcation whereas infection of
Mϕ is abortive and no infectious virus is released (Tate et al., 2010b).
Therefore, infection of murine Mϕ is an important component of early
host defense against inﬂuenza infection. Monolayers of mouse Mϕ or
LA-4 epithelial cells were infected with increasing doses of RG viruses
and immunoﬂuorescence was used to determine the percentage of
infected cells 8 h later. Removal of glycosylation site 165 from Beij/89
HA or sequential removal of multiple sites (i.e. −63/126 or −165/
246) was associated with enhanced infection of LA-4 epithelial cells
(Fig. 3A), particularly when a low inoculum dose was used. These data
might reﬂect the increased ability to bind 〈(2,3)-Gal-linked Neu5Gc
(Table 1A), a linkage expressed at high levels onmouse epithelial cells
(Glaser et al., 2007; Ning et al., 2009).
We have recently demonstrated that receptor speciﬁcity of the HA
is important in determining the ability of a particular virus to infect
murine Mϕ as these cells express high levels of α(2,6)-Gal-linked SA,
but littleα(2,3)-Gal-linked SA (Tate et al., 2011). Nomajor differences
were noted in the ability of RG glycosylation mutants to recognize
α(2,6)-Gal-linked SA (Table 1). Consistent with these ﬁndings, we did
not observe major differences between WT virus or glycosylation
mutants in their ability to infect murine Mϕ (Fig. 3B).
Sensitivity of glycosylation mutants to neutralization via mouse BAL
Wenext determined if removal of glycosylation sites from the Beij/
89 HA altered sensitivity to neutralization bymouse BAL, a rich source
of the collectin SP-D. Consistent with data in Fig. 1B, RG viruses
expressing WT Beij/89 HA were very sensitive to neutralization by
mouse BAL (Fig. 3C). Removal of single glycosylation sites at Asn63 or
Asn126 did not alter sensitivity whereas single-step mutants lacking
Asn165 and, to a lesser extent, Asn246 were less sensitive to
neutralization. Similar results were obtained when assessing the
sensitivity of single-step glycosylation mutants to the plant lectin
concanavalin-A which also binds to high-mannose and hybrid-type
glycans (data not shown).
Compared to virus expressing WT HA, the −63/126 mutant
showed reduced sensitivity, suggesting that these sites can inﬂuencesensitivity to mouse BAL as well as virulence in mice (Fig. 2A). It is
possible that Asn63 and Asn126 carry glycans that are not readily
accessible to SP-D or bear terminal sugars that are recognized poorly
by SP-D (for example, complex glycans terminated in galactose).
Consistent with reports that both Asn165 and Asn246 carry glycans
recognized by SP-D (Hartley et al., 1997; Reading et al., 2009), the
−165/246 mutant was markedly more resistant to mouse BAL than
either −165 or −246 single-step mutants. These data suggest that
accessibility and/or the nature of particular glycans may be particu-
larly important in determining sensitivity of inﬂuenza viruses to
lectin-mediate innate immune defenses. Further experiments are
required to determine the nature of the speciﬁc glycans expressed at
glycosylation sites Asn63, Asn126, Asn165 and Asn246 of Beij/89 HA.Replication of RG viruses with altered glycosylation in vitro and in vivo
BJx109 did not induce disease in mice (Fig. 1), nor did a RG virus
expressing 7 genes from PR8 in conjunction with the Beij/89 HA gene
(Figs. 1 and 2). In contrast, −246 and −165 RG viruses showed
enhanced virulence in mice (Fig. 2A) and−165/246 was particularly
virulent (Fig. 2B). Next, we investigated parameters associated with
disease severity following infection of mice with RG viruses expres-
sing WT HA, single-step glycosylation mutants (−165, −246) or the
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with 103 PFU, the time at which mice infected with −165/246
succumbed to disease (Fig. 2B).
Mice were infected with 103 PFU of RG-Beij/89-HA (WT), −165,
−246 or−165/246 viruses and viral titers in the upper (nasal tissues)
and lower (lung) respiratory tract were determined (Fig. 4). Low
levels of infectious virus were detected in the lungs and nasal tissues
of mice inoculated with virus expressing WT HA, whereas higher
titers of virus were detected in mice infected with −165, −246 or
−165/246 viruses. In particular, titers in the lungs and nasal tissues of
mice infected with −165/246 were ~300-fold and ~50-fold higher,
respectively, when compared to titers recovered from mice infected
with WT.
Given the marked differences in replication of RG viruses in vivo,
we compared the ability of these viruses to replicate in LA-4 mouse
epithelial cells to determine if there were intrinsic differences in their
ability to replicate per se. In these experiments, LA-4 cells were
infectedwith 106 PFU of each virus and supernatants were removed at
2 and 24 h post-infection and assayed for levels of infectious virus
using TCID50. No signiﬁcant differences were noted in the fold
increase in infectious virus between 2 and 24 h for −165, −246 or
−165/246 viruses compared to RG-Beij-HA (data not shown). These
data indicate that differences in the ability of virus to replicate in the
airways of mice are likely due to differences in susceptibility to host
defenses rather than inherent differences in their ability to infect and
replicate in airway epithelial cells.Fig. 5. Increased cellularity, production of inﬂammatory mediators in the airways and
vascular leak is associated with severe disease in mice infected with RG glycosylation
mutants. Groups of 4 mice were infected with 103 PFU of RG viruses bearingWT Beij/89
HA or with −165, −246 or −165/246 glycosylation mutants. At day 5 post-infection,
mice were killed and analyzed. Naïve animals were included for comparison. (A) Total
BAL cells, and (B) numbers of leukocyte subsets in BAL were determined by ﬂow
cytometry for the presence of neutrophils (Neut, Gr-1high), NK cells (NK1.1+ TCRβ−),
B cells (B220+), total T cells (TCRβ+) and CD8+ T cells (CD8+ TCRβ+). Bars represent
the mean cell number±1 SD. *Cell numbers signiﬁcantly different to those from mice
infected with RG virus expressing WT HA (pb0.05, one-way ANOVA). (C) Levels of
MCP-1, TNF-α, IFN-γ and IL-6 in cell-free BAL supernatants were determined by
cytokine bead array. Naïve animals (N) were included from comparison. Bars represent
themean concentration (pg/ml) and individual mice are shown as circles. The detection
limit of each mediator is 5 pg/ml and is indicated as a horizontal dashed line. *Levels inCellularity and production of inﬂammatory mediators in the airways of
mice infected with RG glycosylation mutants
The total number of BAL cells was determined 5 days after
infection with 103 PFU of RG virus expressing WT HA or −165,
−246 or −165/246. Low cell numbers were recovered from the
airways of mice infected with WT HA (Fig. 5A). Infection of mice with
an equivalent dose of −165 and −246 viruses was associated with
recruitment of increased numbers of leukocytes to the airways such
that cell numbers were ~2-fold higher than those from mice infected
with WT. Infection with−165/246, however, resulted in recruitment
of much greater numbers of cells into the airways. BAL cell numbers
from mice infected with−165/246 were ~6-fold higher compared to
cell numbers recovered from mice infected with WT.
To examine the cellular inﬁltrate in detail, BAL cells were analyzed
by ﬂow cytometry at day 5 post-infection and numbers of neutrophils,
NK cells, T cells, CD8+ T cells and B cells were determined (Fig. 5B).
Neutrophils and T cells were the predominant cell types in BAL
following infection with each virus. Overall, infection with−165/246
was associated with increased numbers of neutrophils, NK cells, CD8+Fig. 4. Reduced glycosylation of Beij/89 HA correlates with increased virus growth in
the respiratory tract of mice. Mice were infected with 103 PFU of RG viruses bearing
(i) Beij/89 HA (WT), or (ii) Beij/89 HA glycosylation mutants −165, −246 or −165/
246. Mice were killed and analyzed at day 5 post-infection. Titers of infectious virus in
(i) lung and (ii) nasal tissue homogenates were determined by immunoﬂuorescence on
MDCK cells. Bars represent the mean viral titer from a group of 4 mice±1 SD. The
detection limit of the assay (2.4) is indicated by the dotted line. *Virus titers
signiﬁcantly higher than from mice infected with RG virus bearing WT HA (pb0.01,
one-way ANOVA).
BAL signiﬁcantly elevated compared to levels frommice infected with virus bearingWT
HA (pb0.05, one-way ANOVA). (D) Total protein levels in cell-free BAL supernatants.
Bars represent the mean±1 SD. *Signiﬁcantly elevated compared to mice infected with
RG virus expressing WT HA (pb0.05, one-way ANOVA).T cells, T cells and B cells compared toWT. At day 5 post-infection, the
pulmonary inﬂammation observed in mice infected with −165/246
was also associatedwith a signiﬁcant enhancement in BAL levels of IL-
6, MCP-1, IFN-γ and TNF-α (Fig. 5C), but not IL-10 or IL-12 (data not
shown) when compared to mice infected with WT.
Given that SP-D is the major neutralizing activity in mouse BAL
(Tate et al., 2011), we determined levels of SP-D in BAL from naïve
mice and from mice 5 days after intranasal infection with 103 PFU of
RG viruses expressing WT or mutant HA. SP-D was detected in BAL
from naïve mice (375±58 ng/ml), increased following infection with
RG virus expressing WT HA (615±60 ng/ml), −165 (836±117 ng/
ml) or −246 (829±67 ng/ml), and was highest following infection
with −165/246 (1643±290 ng/ml; n=4–5 animals per group).
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Vascular leak is associated with lung diseases such as ARDS (Luh
and Chiang, 2007) and we have previously demonstrated that severe
disease associated with inﬂuenza virus infection of mice is associated
with pulmonary edema and vascular leakage (Tate et al., 2009; Tate
et al., 2010b). We therefore determined levels of total protein in cell-
free BAL supernatants at day 5 following infection as an indicator of
lung injury. BAL protein levels from mice infected with −165/245
were ~3–4-fold higher than levels in BAL frommice infected with WT
virus (Fig. 5D). Thus, the severe disease observed following infection
of mice with −165/246 was also associated with lung edema and
vascular leak.
Discussion
Inﬂuenza virus infection of murine Mϕ is a complex process
involving binding of the viral HA to cell-surface SA and interactions
between the MMR and glycans expressed on HA/NA glycoproteins
(Reading et al., 2000; Tate et al., 2011; Upham et al., 2010). Removal of
glycosylation sites from the HA of Beij/89 did not reduce the ability of
RG virus to infect murine Mϕ (Fig. 3B). Beij/89 HA shows receptor
preference for α(2,6)-Gal-linked SA (Table 1B) and murine Mϕ
express abundant α(2,6)-Gal-linked SA and little α(2,3)-Gal-linked
SA (Tate et al., 2011). PR8 lacks glycosylation on the head of HA yet
this virus could mediate efﬁcient MMR-mediated infection of Mϕ that
had been desialylated and resialylated to express only α(2,3)-Gal-
linked SA (Tate et al., 2011), indicating that glycans on the NA and/or
the stalk of HA can contribute to MMR-mediated recognition if the
correct SA linkage is provided to ‘tether’ virus to the Mϕ cell surface.
Deletion of particular glycosylation sites from the Beij/89 HA was not
associated with major changes in its ability to recognize α(2,6)-Gal-
linked SA (Table 1B), emphasizing the importance of the match
between HA receptor speciﬁcity and SA linkages expressed at the cell
surface. Moreover, the enhanced virulence of Beij/89 glycosylation
mutant viruses (e.g. −165 and −165/246) was not associated with
reduced ability to infect Mϕ, but rather with reduced sensitivity to
innate inhibitors present in lung ﬂuids.
Acquisition of N-glycosylation at residues 165 and 246 during the
evolution of H3 subtype viruses has been associated with increased
sensitivity to rat SP-D and reduced virulence in mice (Reading et al.,
1997). Moreover, mutant viruses lacking glycosylation at either 165 or
246 of Phil/82 and Beij/89 HA, respectively, were more resistant to rat
SP-D and more virulent in mice (Hartley et al., 1997; Reading et al.,
2009). Using a RG approach we conﬁrm the importance of
glycosylation site Asn165, as mice infected with 105 PFU of a single-
step Beij/89 mutant lacking this site (−165) succumbed to infection
3 days earlier than mice infected with −246 (Fig. 2A). SP-D
represents the major neutralizing activity in mouse BAL that is active
against inﬂuenza viruses and PR8 is largely resistant to SP-D (Tate
et al., 2010a). Glycosylation site 165 is conserved in virtually all H3N2
over the past 40 years (Igarashi et al., 2008) and is critical in
determining sensitivity to β-inhibitors in mammalian serum (Anders
et al., 1990; Hartley et al., 1992). Following introduction into the
human population in 1968, H3 subtype viruses were largely resistant
to SP-D, despite carrying the glycan at site 165. Over time, H3 HA has
gained additional glycosylation and viruses are more sensitive to SP-
D. Of interest, Hartshorn et al. (2008) have proposed that tethering of
SP-D to the viral HA may occur by initial binding to the glycan at 165.
Once bound, SP-D can interact with additional sites, leading to greater
sensitivity to neutralization. In our studies, simultaneous removal of
both sites (−165/246) was associated with resistance to mouse BAL
as well as a further increase in virulence (Fig. 2A/B). These ﬁndings
highlight the importance of SP-D, rather than airway Mϕ, in
modulating virulence in the mouse model of inﬂuenza infection.In addition to determining sensitivity to soluble inhibitors,
removal of glycosylation can alter functional properties of HA.
Consistent with previous reports, (Anders et al., 1990; Hartley et al.,
1997; van Eijk et al., 2004), Beij/89 mutants lacking Asn165 showed an
enhanced ability to bind α(2,3)-Gal-linked Neu5Gc (Table 1B),
demonstrating a clear role in inﬂuencing receptor speciﬁcity. In the
mouse lung, both α(2,3)-Gal and α(2,6)-Gal-linked SA are expressed,
but α(2,3)-Gal-linked SA predominates (Glaser et al., 2007; Ning
et al., 2009) and both Neu5Ac and Neu5Gc SA are expressed on
murine lung epithelial cells (Hedlund et al., 2007; Makatsori et al.,
1998; Markotic et al., 1999). The ability of the −165 and −165/246
mutants to induce severe disease may relate to their resistance to
neutralization by mouse BAL, however their increased ability to bind
α(2,3)-Gal-linked Neu5Gc could also promotemore efﬁcient infection
of epithelial cells in the airways (Fig. 3A).
Infection of mice with 103 PFU of glycosylation mutant−165/246
resulted in rapid weight loss and all animals were euthanized by day 6
post-infection (Fig. 2B). Although a virus lacking all 4 glycosylation
sites from Beij/89 HA could not be rescued, the −165/246 mutant
showed marked increases in (i) ability to induce disease in mice
(Fig. 2), (ii) virus replication in the airways (Fig. 4), (iii) pulmonary
inﬂammation (Fig. 5A/B), (iv) induction of inﬂammatory mediators in
the airways (Fig. 5C), and (v) vascular leak (Fig. 5D). Consistent with
this notion, we have previously demonstrated that PR8-infection of
mice induces severe lung inﬂammation and disease (Tate et al.,
2010a; Tate et al., 2010b). Thus, while expression of Beij/89 HA on a
‘PR8 backbone’ resulted in a virus that was largely avirulent (Fig. 1D/
2A), simultaneous removal of 2 glycosylation sites from the head of
HA resulted in a virus that induced severe disease similar to that of
mouse-adapted PR8.
Studies presented herein were performed using reassortant
viruses expressing Beij/89 HA on a PR8 backbone to facilitate in vivo
experiments using a mouse model. Mice are not naturally infected
with inﬂuenza virus, however the disease observed following
infection with mouse-adapted virus strains such as PR8 recapitulates
a number of aspects of human disease. Although the speciﬁc human
proteins that inhibit inﬂuenza infectivity have not been fully
characterized, SP-D is present in human BAL and has been shown to
mediate antiviral activity against highly glycosylated virus strains
(Hartshorn et al., 1994). While many of our current insights into the
nature of the immune response to inﬂuenza infection have been
gained through studies utilizing the mouse model major differences
exist, including the distribution of particular sialic acid-bearing
receptors throughout the respiratory tract (Glaser et al., 2007;
Nicholls et al., 2009; Ning et al., 2009; Tate et al., 2011). In humans,
understanding the role of innate immune inhibitors against inﬂuenza
virus is also complicated by the presence of antibodies elicited to
previously circulating virus strains. Thus, while studies presented
herein provide evidence that glycosylation is an important determi-
nant of virulence in a mouse model of infection, caution must be
exercised in extrapolating the relevance of these ﬁndings to human
disease.
Together, data presented herein highlight the importance of
soluble lectin-mediated innate defenses in limiting the virulence of
inﬂuenza viruses in mice.We recently demonstrated that inhibition of
lectin-mediated defenses via intranasal treatment of BJx109-infected
mice with mannan, a ligand of both SP-D and MMR, led to a marked
exacerbation in disease severity (Tate et al., 2010a). Moreover,
depletion of airway Mϕ from BJx109-infected mice was associated
with enhanced virus replication and severe disease (Tate et al., 2010b).
Herein, we have used a more reﬁned approach to speciﬁcally remove
particular glycosylation sites from Beij/89 HA (alone or in combina-
tion) to demonstrate that HA glycosylation is critical in determining
sensitivity to neutralization by mouse lung ﬂuids and virulence. In
contrast, removal of glycosylation did not result in major changes in
the ability of RG viruses to infect murine Mϕ. These ﬁndings support
90 M.D. Tate et al. / Virology 413 (2011) 84–92our recent data (Tate et al., 2011) that receptor speciﬁcity of HA, rather
than HA glycosylation, is the major factor determining the ability of
different viruses to infect murine Mϕ. For the glycosylation mutants
described in the current study, susceptibility to innate proteins in lung
ﬂuids, rather than airway Mϕ, appears to be the major determinant
limiting virulence in mice.
Materials and methods
Mice and viruses
C57BL/6 (B6)mice were bred and housed in speciﬁc pathogen-free
conditions at the Department of Microbiology and Immunology,
University of Melbourne. Male mice 6–8 weeks of age were used in all
experiments. The inﬂuenza virus strain used in this study was BJx109,
a high-yielding genetic reassortant of A/PR/8/34 (PR8, H1N1) and A/
Beijing/353/89 (Beij/89, H3N2) that bears the H3N2 surface glyco-
proteins. Viruses were grown in 10-day embryonated eggs by
standard procedures.
Generation of glycosylation mutants via reverse genetics (RG)
Inﬂuenza viruses bearing different HA glycoproteins were rescued
using 8-plasmid reverse genetics as described (Hoffmann et al., 2002).
Site-directed mutagenesis was performed to sequentially remove
potential N-linked glycosylation sites from the globular head of the
HA of Beij/89 (H3). Removal of N-glycosylation sites was achieved by
substituting asparagine (Asn) with alanine (Ala) in the glycosylation
sequence motif Asn-X-Ser/Thr. Mutations were introduced into the
HA gene by the QuikChange® Site Directed Mutagenesis Kit
(Stratagene La, Jolla, CA) and the sequence of the mutated cDNA
veriﬁed by DNA sequencing. Viruses generated were 7:1 reassortants
consisting of the 7 gene ‘PR8 backbone’ with either wild type or
glycosylation mutant HA gene from Beij/89. Plasmid vectors contain-
ing the 7 genes of PR8 were kindly provided by Dr. RobertWebster, St.
Jude Children's Research Hospital, Memphis, TN, USA. The HA gene of
all rescued viruses were sequenced to ensure (i) that appropriate
mutations were retained, and (ii) that no additional mutations were
introduced.
Quantiﬁcation of infectious virus
Titers of infectious virus were determined by standard plaque
assay on Madin-Darby canine kidney (MDCK) cells (Anders et al.,
1994), however the plaque size formed by particular glycosylation
mutant viruses were too small to count accurately. Therefore, titers of
RG viruses were determined using an immunoﬂuorescence assay.
Monolayers of MDCK cells cultured in 96-well plates (Nunc, USA)
were inoculated with dilutions of virus, incubated for 1 h at 37 °C in
5% CO2 and, after washing, incubated for a further 6–8 h. Cells were
then washed, ﬁxed with 80% (v/v) acetone in water and stained for
the presence of newly synthesized viral nucleoprotein (NP) using
mAb MP3.10G2.IC7 (WHO Collaborating Centre for Reference and
Research on Inﬂuenza, Melbourne, Australia), followed FITC-conju-
gated sheep anti-mouse immunoglobulin (Silenus, Australia). Plates
were viewed under 100× magniﬁcation and the total number of
ﬂuorescent foci in duplicate wells was used to calculate infectivity
titers.
In some experiments, the 50% tissue culture infective dose
(TCID50) was determined using monolayers of MDCK cells in ﬂat
bottom 96-well tissue culture plates (Nunc, USA). Cell supernatants
were titrated and incubated at 37 °C, 5% CO2 for 3 days in the presence
of 2 μg/ml trypsin (TPCK-treated, Worthington Biochemical, USA).
Monolayers were visualized using light microscopy and the dilution
where pathological change in 50% of cell cultures was observed wasused to calculate the TCID50 titer, expressed in TCID50/ml of original
sample.
Desialylation and resialylation of erythrocytes
Methods for the enzymatic modiﬁcation of erythrocyte oligosac-
charides have been described previously (Rogers and Paulson, 1983).
In brief, suspensions (10%) human erythrocytes were desialylated
with 600 mU/ml of C. perfringens sialidase for 1 h at 37 °C, washed
twice and resialylated using 1.5 mM CMP-N-acetylneuraminic acid
(NeuAc, Sigma Aldrich) and 4 mU of either β-galactoside-α2,3-
sialyltransferase (Japan Tobacco INC, Shizuka, Japan) or β-D-Galacto-
syl-β1,4-N-acetyl-β-D-glucosamine-α2,6-sialyltransferase (Merck,
USA), or with buffer alone (sham treated) at 37 °C for 4 h.
Erythrocytes were washed in tris-buffered saline (TBS) and used in
standard hemagglutination (HA) titrations.
Virus neutralization assay
To examine the ability of bronchoalveolar lavage (BAL) ﬂuids to
neutralize virus infectivity, naïve mice were euthanized and the lungs
ﬂushed three times with 1 ml of TBS through a bunted 23-guage
needle inserted into the trachea. BAL ﬂuids were clariﬁed by
centrifugation and supernatants frozen at −20 °C. Neutralization of
inﬂuenza virus infectivity was measured by ﬂuorescent-focus reduc-
tion in monolayers of MDCK cells cultured in 96-well plates as
described (Reading et al., 1997). Brieﬂy, BAL supernatants were
diluted in TBS supplemented with 10 mM CaCl2 (TBS-Ca) and
incubated with a constant amount of virus for 30 min at 37 °C prior
to their addition to MDCK cell monolayers. Inﬂuenza virus-infected
cells were detected by immunoﬂuorescence microscopy as described
above. The total number of FF in four representative ﬁelds was
counted and expressed as a percentage of the number of foci in the
corresponding area of duplicate control wells infected with virus
alone. Each virus stock was diluted such that it resulted in 50–200
ﬂuorescent foci per ﬁeld when incubated in TBS-Ca alone (i.e. the
virus alone control).
Infection of mouse Mϕ and epithelial cells
Mouse peritoneal exudate cell (PEC) Mϕ or the murine LA-4 lung
epithelial cell line were prepared and infected with virus in 8-well
chamber slides as previously described (Reading et al., 1997). Slides
were stained for expression of inﬂuenza virus NP as described above.
The percentage of ﬂuorescent cells was determined in a minimum of
four random ﬁelds with a minimum of 200 cells counted for each
sample. To test for inhibition of infection by yeast mannan (Sigma-
Aldrich, USA), cells were incubated with mannan (ﬁnal concentration
10 mg/ml) for 30 min at room temperature before addition of virus.
To determine the titer of infectious virus present in supernatants
from inﬂuenza virus-infected LA-4 epithelial cells, cell monolayers
were incubated with 106 plaque-forming units (PFU) of each virus for
60 min, washed three times to remove free virus and cultured at 37 °C.
At 2 and 24 h post-infection, supernatants were removed and the
presence of infectious virus determined by standard TCID50 on MDCK
cell monolayers in the presence of trypsin.
Virus infection of mice
Mice were anesthetized and infected with 105 PFU or 103 PFU of
inﬂuenza viruses via the intranasal (i.n.) route in 50 μl of PBS. Mice
were weighed daily and assessed for visual signs of clinical disease
including inactivity, rufﬂed fur, labored breathing and huddling
behaviour. Animals that had lost ≥25% of their original body weight
and/or displayed evidence of pneumonia were euthanized. All
research complied with the University of Melbourne's Animal
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infection, mice were euthanized and the lungs, nasal tissues, brain and
hearts were removed, homogenized in PBS and clariﬁed by centrifu-
gation. Titers of infectious virus in tissue homogenates were
determined by using immunoﬂuorescence assay as described above.
Recovery and characterization of leukocytes from mice
BAL cells were obtained as described (Tate et al., 2008). Samples
were treated with Tris–NH4Cl (0.14 M NH4Cl in 17 mM Tris, adjusted
to pH 7.2) to lyse erythrocytes and washed in RPMI 1640 medium
supplemented with 10% FCS. Cell numbers and cell viability were
assessed via trypan blue exclusion.
For ﬂow cytometric analysis, single cell suspensions prepared from
the BAL were incubated on ice for 20 min with supernatants from
hybridoma 2.4G2 to block Fc receptors, followed by staining with
appropriate combinations of ﬂuorescein isothiocyanate (FITC)-,
phycoerythrin (PE)- or allophycocyanin (APC)-conjugated mAbs
speciﬁc for Gr-1 (RB6-8C5), CD45.2 (104), CD8α (53–6.7), B220
(RA3-6B2), TCRβ (H57-597) and NK1.1 (PK136). Living cells were
identiﬁed by the addition of 10 μg/ml PI to each sample and cells were
analyzed using a FACS Calibur ﬂow cytometer. A minimum of 50,000
PI− cells were collected.
Cytokine bead array for the detection of inﬂammatory mediators
The levels of IFNγ, TNFα, IL-6, IL-10, IL-12.p70 and MCP-1 in BAL
supernatants and serumwere determined using a BD cytometric Bead
Array (CBA) mouse inﬂammation kit (Becton Dickinson, USA)
according to manufacturer's instructions. The detection limit for the
assay was 5 pg/ml for all cytokines tested.
ELISA for SP-D levels in mouse BAL
Levels of SP-D (ng/ml) in mouse BAL were determined by ELISA
using recombinant rat SP-D as a standard, as described (Reading et al.,
1997).
Assessment of vascular leak
The concentration of protein in cell-free BAL supernatant was
measured by adding Bradford protein dye. A standard curve using BSA
was constructed and the OD determined at 595 nm.
Statistical analysis
For the comparison of two sets of values, a Student's t-test (two-
tailed, two-sample equal variance) was used. When comparing three
or more sets of values, data were analyzed by one-way ANOVA
(nonparametric) followed by post-hoc analysis using Tukey'smultiple
comparison test. Survival proportions were compared using the
Mantel Cox log rank test. A p value of ≤0.05 was considered
statistically signiﬁcant.
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